◆ 会议时间:2024年9月13-17日
◆ 会议地点:西班牙 巴塞罗那
◆ 会议简介:
2024年欧洲肿瘤内科学会(ESMO)年会/大会将于2024年9月13-17日在西班牙巴塞罗那举行,会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议,每年都有超过30,000名专业人士参加会议;届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂,一起分享了解肿瘤学领域的最新进展,并将科学转化为最佳的癌症患者护理。ESMO大会科学计划将由一个300多名国际专家组成的委员会制定,内容涵盖从基础研究到癌症免疫治疗的最新发现,从肿瘤护理到姑息治疗,从罕见癌症到药物批准,等等。ESMO年度大会将成为转化研究、呈现实践变化数据宣和多学科讨论的卓越全球平台,大会将提供优秀的科学教育计划,为代表们提供了丰富的交流意见的机会。(2020ESMO虚拟年会数字:30000余名与会者来自150多个国家/地区;230余位演讲嘉宾;2137份摘要提交)
欧洲肿瘤内科学会(ESMO)成立于1975年,是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会,现在全球160多个国家和地区拥有超过25,000余名会员;ESMO致力于通过宣促进多学科的癌症护理,支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理,尽而为癌症患者提供最佳的护理。未经本站许可,禁止复制转载摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com)。
ESMO 2024 - European Society of Medical Oncology (ESMO) Congress 2024
Date: 13-17 September 2024
Venue: Barcelona, Spain
The ESMO Congress is the most influential oncology platform designed in Europe for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO Congress 2024 will again present the very latest advances in the treatment of cancer and offer an excellent educational programme, with a wealth of opportunities for exchange of ideas among delegates.
摘要征文投稿:
Abstract submission deadlines-征稿截止日期
Deadline |
Date and time |
Abstract
Trial in Progress
Intent to submit LBA |
7 May 2024, 21:00hrs CEST
(CEST = Central European Summer Time) |
Late-breaking abstracts |
7 August 2024, 21:00hrs CEST
(CEST = Central European Summer Time)
A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 7 May 2024. |
点此提交摘要>>>Submit Abstract>>>
ESMO Congress 2024 Abstract Regulations
Outcome notifications-结果通知
Outcome notifications are expected to be made available to first authors and submitters by mid July 2024.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by mid August 2024.
Information for presenters-演示者信息
Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid July 2024, in the section “Information for Presenters”.
Abstract submission categories-摘要提交类别
Basic science |
NSCLC, metastatic |
Biliary tract cancer, incl. cholangiocarcinoma |
Oesophagogastric cancer |
Biomarkers & translational research (agnostic) |
Palliative care |
Breast cancer, early stage |
Pancreatic cancer |
Breast cancer, locally advanced |
Policy and preventive strategies |
Breast cancer, metastatic |
Prostate cancer |
CNS tumours |
Psycho-oncology |
Colorectal cancer |
Renal cancer |
Developmental therapeutics |
Sarcoma |
Endocrine tumours |
SCLC |
Germ cell (testicular) cancer and penile cancer |
Supportive care |
Gynaecological cancers |
Thoracic malignancies, other |
Haematological malignancies |
Thyroid cancer |
Head and neck cancer, excluding thyroid |
Tumour biology and pathology |
Hepatocellular carcinoma (HCC) |
Urothelial cancer |
Investigational immunotherapy |
*Cancer Nursing: Advance care planning and palliative care |
Melanoma and other skin tumours |
*Cancer Nursing: eHealth and digital innovations |
Miscellaneous |
*Cancer Nursing: Health promotion, prevention and screening |
Neuroendocrine tumours |
*Cancer Nursing: Leadership and educational issues in cancer nursing |
New diagnostic tools |
*Cancer Nursing: Precision health |
NSCLC, early stage |
*Cancer Nursing: Rehabilitation and survivorship care |
NSCLC, locally advanced |
*Cancer Nursing: Symptom management |
*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO 2024 submission regulations and guidelines.
Late-breaking abstracts (LBA) - 最新突破性数据摘要
Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 7 August 2024 is under no circumstances to be considered as an extension of the general submission deadline.
Trial in progress abstracts (TiP)-进行中的试验摘要
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Congress 2024.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Presentation of accepted abstracts
The ESMO Congress 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium - Oral presentations of cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper – Oral presentations of original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentation of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts will be published in the ESMO Congress 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
Publication schedule of accepted abstracts
Details regarding the publication of accepted abstracts will be available in the Press & Media page soon.
ESMO2024 注册费:
Registration fees for on-site and online
(21% Spanish VAT included) |
Early registration
until 12 June 2024 |
Late registration
until 7 August 2024 |
Full registration
from 8 August 2024 |
ESMO Member |
€ 647 |
€ 910 |
€ 1,160 |
ESMO Member Developing Countries* |
€ 182 |
€ 290 |
€ 327 |
ESMO Member in Training** |
€ 101 |
€ 136 |
€ 203 |
ESMO Member Undergraduate Student |
€ 101 |
€ 136 |
€ 203 |
ESMO / EONS Member Nurse |
€ 540 |
€ 540 |
€ 540 |
ESMO Member Patient Advocate |
€ 101 |
€ 136 |
€ 203 |
EONS Early Career Nurse |
€ 101 |
€ 101 |
€ 101 |
Non-Member |
€ 1,010 |
€ 1,280 |
€ 1,550 |
* Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO members must be under 40 and in training to qualify for this fee.
In-person participation includes:
- Admission to on-site scientific and educational sessions with the possibility to interact with Speakers, Chairs and panels
- On-site networking opportunity with faculty and peers
- Entry to the Poster area
- Interaction with industry partners in the trade exhibition
- Participation in the Industry Satellite Symposia
- Access to the Virtual Congress Platform to follow sessions live and/or view content on-demand
- Post-event resources
Online participation includes:
- Access to the Virtual Congress Platform, with live streaming of all sessions
- Possibility to interact through the chat live feature
- Access to e-Posters
- Entry to the Virtual Exhibition
- Participation in the Industry Satellite Symposia
- Post-event resources
Other registration fees for on-site only (21% Spanish VAT included) - virtual platform not included |
Fee |
Access |
Private Meeting badge |
€ 253 |
Access to Exhibition & Satellites, private meeting & business rooms only |
Industry Symposium badge |
€ 253 |
Access to Exhibition & Satellites, private meeting & business rooms only |
Exhibitor Visitor badge |
€ 126 |
Exhibition area only |
ESMO2024-欧洲肿瘤年会-ESMO欧洲肿瘤内科学会2024-ESMO年会/大会-ESMO Congress 2024
◆ 参会对象:
肿瘤科医师、放射科医师,介入放射科医师,外科/普外科医师,病理科医师,护士以及从事肿瘤护理与研究的其他相关专业人士等。
|